Vidcast:  https://youtu.be/1bFzIS-FByU

The infamous and now convicted Elizabeth Holmes who founded the Silicon Valley startup Theranos made the same promise and utterly failed. Now, geneticists at Stanford University, where ironically Holmes once attended college and dropped out, announce the development of so-called multi-omics technologies that really can make needle-shy patients’ wishes come true.

The multi-omics technology employs ether extraction to separate fatty metabolites from the non-fatty, methanol to sequester proteins, and an aqueous extraction for immunoassay of cytokines and hormones. Analysis of the thousands of compounds in each mix using mass spectrometry permits a frequent assay of them and the development of what the investigators call metabolic phenotypes.

Combining this data with that from wearables will someday permit medical teams to monitor the metabolic and physical health of patients on a 24/7 basis.

https://www.nature.com/articles/s41551-022-00999-8#Sec17

#multiomics #laboratories #clinicalpanels #monitoring #metabolism #theranos